UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis

World journal of gastroenterology : WJG, 2008-03, Vol.14 (10), p.1549-1552

2008

Volltextzugriff (PDF)

Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits

World journal of gastroenterology : WJG, 2005-04, Vol.11 (13), p.1987

2005

Volltextzugriff (PDF)

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

World journal of gastroenterology : WJG, 2006-08, Vol.12 (29), p.4716

2006

Volltextzugriff (PDF)

Compliance with the clinical practice guidelines for the management of hepatitis B and C virus-related chronic liver disease: a survey based on hospitalized cirrhotic patients

Italian journal of medicine, 2013-01, Vol.7 (2), p.107-112

2013

Volltextzugriff (PDF)

Current practice of hepatitis C treatment in Southern Italy

Digestive and liver disease, 2010-11, Vol.42 (11), p.822-825

2010

Volltextzugriff (PDF)

High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder

Hepato-gastroenterology, 2010-09, Vol.57 (102-103), p.1215

2010

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver

Digestive and liver disease, 2004-06, Vol.36 (6), p.398-405

2004

Volltextzugriff (PDF)

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

Transplant international, 2008-05, Vol.21 (5), p.502-504

2008

Volltextzugriff (PDF)

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Hepatology (Baltimore, Md.), 1995-08, Vol.22 (2), p.389-394

1995

Volltextzugriff (PDF)

Soluble CD30 serum levels before and after treatment with I--interferon in patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2005-08, Vol.43 (8), p.823-826

2005

Volltextzugriff (PDF)

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Hepatology (Baltimore, Md.), 1995, Vol.22 (2), p.389-394

1995

Volltextzugriff (PDF)

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C

Le infezioni in medicina, 2003-12, Vol.11 (4), p.208

2003

Volltextzugriff (PDF)

Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2005, Vol.43 (8), p.823-826

2005

Volltextzugriff (PDF)

Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size

Hepato-gastroenterology, 2002-09, Vol.49 (47), p.1382

2002

Volltextzugriff (PDF)

Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta-analysis of individual patient data

Digestive and liver disease, 2001-11, Vol.33, p.A60-A60

2001

Volltextzugriff (PDF)

Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up

Hepato-gastroenterology, 1999-11, Vol.46 (30), p.3229

1999

Volltextzugriff (PDF)

Ten year follow-up of patients with chronic hepatitis C treated with interferon

Hepato-gastroenterology, 1999-07, Vol.46 (28), p.2447

1999

Volltextzugriff (PDF)

Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon

Hepato-gastroenterology, 1997-09, Vol.44 (17), p.1295

1997

Volltextzugriff (PDF)

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

Transplant international : official journal of the European Society for Organ Transplantation, 2008, Vol.21 (5), p.502-504

2008

Volltextzugriff (PDF)

Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19

Cells (Basel, Switzerland), 2024-09, Vol.13 (18), p.1576

2024

Volltextzugriff (PDF)

A non-conserved amino acid variant regulates differential signalling between human and mouse CD28

Nature communications, 2018-03, Vol.9 (1), p.1080-16, Article 1080

2018

Volltextzugriff (PDF)

Bifacial dye-sensitized solar cells for indoor and outdoor renewable energy-based application

Journal of materials chemistry. C, Materials for optical and electronic devices, 2024-02, Vol.12 (7), p.2317-2349

2024

Volltextzugriff (PDF)

MP59-07 IS URETHRAL-SPARING ROBOT-ASSISTED SIMPLE PROSTATECTOMY READY FOR PRIME TIME?

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis

Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

Compliance with the clinical practice guidelines for the management of hepatitis B and C virus-related chronic liver disease: a survey based on hospitalized cirrhotic patients

Current practice of hepatitis C treatment in Southern Italy

High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder

Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Soluble CD30 serum levels before and after treatment with I--interferon in patients with chronic hepatitis C

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C

Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C

Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size

Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta-analysis of individual patient data

Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up

Ten year follow-up of patients with chronic hepatitis C treated with interferon

Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

Sulfated Bile Acids in Serum as Potential Biomarkers of Disease Severity and Mortality in COVID-19

A non-conserved amino acid variant regulates differential signalling between human and mouse CD28

Bifacial dye-sensitized solar cells for indoor and outdoor renewable energy-based application

Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation

MP59-07 IS URETHRAL-SPARING ROBOT-ASSISTED SIMPLE PROSTATECTOMY READY FOR PRIME TIME?

Suchergebnisse filtern